Benzinga | Aug 5, 2021 04:22PM EDT

Axonics Modulation Tech Q2 EPS $(0.59) Misses $(0.49) Estimate, Sales $45.90M Beat $39.82M Estimate

Axonics Modulation Tech (NASDAQ:AXNX) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.49) by 20.41 percent. This is a 9.26 percent decrease over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $45.90 million which beat the analyst consensus estimate of $39.82 million by 15.27 percent. This is a 201.72 percent increase over sales of $15.21 million the same period last year.